Inflexion Raises 2.3 Billion Continuation Fund for Four Key Assets
Deal News | May 15, 2025 | William Blair Capital Partners
Inflexion, a prominent European mid-market private equity firm, has successfully closed a 2.3 billion multi-asset continuation fund, known as the Inflexion Continuation Fund I. The fund was closed in May 2025 and is aimed at continuing the long-term development of four major assets: Aspen Pumps, Rosemont Pharmaceuticals, Ocorian, and CNX Therapeutics. Acting as a financial advisor, William Blair supported Inflexion in this strategic endeavor. Inflexion invests in companies with enterprise valuations ranging between 50 million and 1 billion and is committed to accelerating growth through various strategies such as M&A, international expansion, and digital enhancement. With over 11 billion in funds under management, Inflexion continues to drive sustainable growth through its global offices, positioned in cities like London, New York, and Amsterdam.
Sectors
- Private Equity
- Pharmaceuticals
- Manufacturing
- Financial Services
Geography
- United Kingdom – Two of the key assets, Rosemont Pharmaceuticals and Aspen Pumps, are based in the UK.
- Europe – Inflexion is a European-focused private equity firm, and CNX Therapeutics is described as a European pharmaceutical platform.
- Global – Ocorian and other Inflexion offices and interests span globally, including New York and Amsterdam.
Industry
- Private Equity – Inflexion is a private equity firm involved in raising a multi-asset continuation fund.
- Pharmaceuticals – Assets such as Rosemont Pharmaceuticals and CNX Therapeutics are in the pharmaceutical sector.
- Manufacturing – Aspen Pumps operates in the manufacturing and distribution of condensate pumps.
- Financial Services – Ocorian is involved in fund, corporate, and fiduciary services, placing it in the financial services industry.
Financials
- 2.3 billion – Total size of the multi-asset continuation fund raised by Inflexion.
- 11 billion – Total funds under management by Inflexion Private Equity Partners LLP.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Inflexion | Private Equity Firm | Company | Inflexion is a European mid-market private equity firm managing 11 billion in funds. |
| William Blair Capital Partners | Financial Advisor | Company | Served as the financial advisor to Inflexion for the continuation fund. |
| Aspen Pumps | Asset | Company | Global manufacturer and distributor of condensate pumps. |
| Rosemont Pharmaceuticals | Asset | Company | UK's leading liquid pharmaceuticals business. |
| Ocorian | Asset | Company | Provides global fund, corporate, and fiduciary services. |
| CNX Therapeutics | Asset | Company | European speciality pharmaceutical platform. |